Neuropsychological Impact of Hospitalization on Intubated, Ventilated and Sedated ICU Patients
NCT01838798, Not applicable, Completed, Centre Hospitalier Universitaire de Nīmes
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Neuropsychological Impact of Hospitalization on Intubated, Ventilated and Sedated ICU Patients | ClinicalTrials.gov |
| NCT number | NCT01838798 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 125 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Centre Hospitalier Universitaire de Nīmes | ClinicalTrials.gov |
| Conditions | Stress Disorders, Post-Traumatic, Depression | ClinicalTrials.gov |
| Interventions | Baseline activities, Clinical interview with a psychologist, Telephone interview 2 months after ICU discharge, Clinical interview with a psychologist | ClinicalTrials.gov |
| First posted | 2013-04-24 | ClinicalTrials.gov |
| Last updated | 2025-12-19 | ClinicalTrials.gov |
Registered outcomes 24
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Presence/absence of cognitive impairment | 4 months after ICU discharge | based on D2 test | ClinicalTrials.gov |
| Secondary | Duration of sedation | expected average of 48 hours | ClinicalTrials.gov | |
| Secondary | Duration of ventilation | expected average of 36 hours | ClinicalTrials.gov | |
| Secondary | Daily average for RASS scale | Expected maximum of 28 days | ClinicalTrials.gov | |
| Secondary | Daily average for Behaviour pain scale | expected average of 48 hours | ClinicalTrials.gov | |
| Secondary | CAM ICU score | upon awakening (expected average of 48 hours) | ClinicalTrials.gov | |
| Secondary | Peritraumatic distress inventory | expected average of 5 days (end of ICU stay) | ClinicalTrials.gov | |
| Secondary | Questionnaire PDEQ-10 | expected average of 5 days (end of ICU stay) | ClinicalTrials.gov | |
| Secondary | Assessment of potential impacts | expected average of 5 days (end of ICU stay) | ClinicalTrials.gov | |
| Secondary | HADS score | expected average of 5 days (end of ICU stay) | ClinicalTrials.gov | |
| Secondary | ICUMT questionnaire | 60 +- 3 days after ICU discharge | ClinicalTrials.gov | |
| Secondary | ICU-SEQ questionnaire | 60 +- 3 days after ICU discharge | ClinicalTrials.gov | |
| Secondary | Assessment of psychotramatisme | 60 +- 3 days after ICU discharge | ClinicalTrials.gov | |
| Secondary | HADS score | 60 +- 3 days after ICU discharge | ClinicalTrials.gov | |
| Secondary | PCLS scale (DSM IV items) | 4 months after ICU discharge | ClinicalTrials.gov | |
| Secondary | IDS-C Questionnaire | 4 months after ICU discharge | ClinicalTrials.gov | |
| Secondary | SF-36 | 4 months after ICU discharge | ClinicalTrials.gov | |
| Secondary | Forward span test | 4 months after ICU discharge | ClinicalTrials.gov | |
| Secondary | Backwards span test | 4 months after ICU discharge | ClinicalTrials.gov | |
| Secondary | Rey 15-word test | 4 months after ICU discharge | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Verbal Fluency | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)